Marijuana Stocks & Public Companies

5 Tips From the Trenches for Pitching Your Cannabis Business to Investors

By John Schroyer Investment money is finally flowing into the cannabis industry as the business risks subside and marijuana goes mainstream. Scores of deep-pocketed investors are actively seeking opportunities to fund everything from dispensaries and grow operations to ancillary businesses that don’t directly handle marijuana. “It’s like the perfect time to be raising capital,

Read More

Edibles Company Seeks $5M in Private Stock Offering for Expansion

Infused products manufacturer G FarmaLabs is looking to raise $5 million though a private stock offering to expand its presence in California and pave the way for national growth. The company plans to sell up to 2 million shares of common stock – at $2.50 each – to qualified investors in California, according to a […]

Read More

Consultant Company Pursues IPO-Friendly Restructure

Mjardin Management isn’t exactly an original idea, given that it’s a consulting and management company with a focus on the “cultivation and sale of premium cannabis.” But its restructuring plan demonstrates the company’s ambition. According to The New York Times, Mjardin plans to announce on Wednesday that it has reorganized the firm, with the main […]

Read More

Ex-CEO of Tweed an Overnight Multimillionaire

Many parallels have been drawn to date between the development of the cannabis industry and the dot-com era of the 1990s, when the technology sector experienced unparalleled growth. This week brings news of another reason to think that the comparison may be valid. The former CEO of Tweed, a publicly traded Canadian marijuana cultivation firm, […]

Read More

Investors Welcome 2 New Canadian MMJ Stocks

Two Canadian cannabis cultivation companies saw their share prices soar on the first day of trading as investors look to capitalize on a booming industry. Bedrocan Cannabis Corp, which trades on the Toronto Stock Exchange under the symbol BED, rose as high as 1.45 Canadian dollars ($1.32) on Monday before closing at CA$1.17, about 38% […]

Read More

Canadian Cultivation Company’s Stock to Debut Monday

A Canadian company is set to become just the second licensed medical cannabis cultivation business in the country to go public. Bedrocan Canada Inc. has reportedly received approval to list on the Toronto Venture Exchange under the ticker symbol BED, and its stock is scheduled to debut on Monday, according to Reuters. The company will […]

Read More

SEC Charges Traders With Marijuana Stock Manipulation

Four stock traders have been charged by the U.S. Securities and Exchange Commission with manipulating shares of cannabis companies in a pump-and-dump scheme. The stocks affected include GrowLife and Hemp Inc., as well as some non-cannabis securities. The defendants allegedly used manipulative tactics to create the appearance of heavy trade volume, which in turn caused […]

Read More

Bhang Terminates Relationship With Mentor Capital

One of the most eye-opening financing deals in the cannabis industry has fallen apart. Edibles manufacturer Bhang Chocolate is terminating an agreement to sell a majority stake in the company to the publicly traded firm Mentor Capital. In a a press release, Bhang declared Mentor Capital in breach of the agreement, adding that it has […]

Read More

UK Company Raising $148M to Advance CBD Drug

British drug maker GW Pharmaceuticals plans to raise $148 million from U.S. investors to advance an epilepsy drug that uses cannabidiol (CBD). The company will sell 1.7 million American Depository Shares on the Nasdaq – where it trades under the symbol GWPH – priced at $86.83 each. The drug, called Epidiolex, contains cannabidiol oil extracted […]

Read More

Investors Warned About Canadian Cannabis Stocks

Canadian securities officials are warning investors to be cautious of publicly traded medical marijuana companies. In a release, the Canadian Securities Administrators said that public companies could be misleading investors about their business plans and employing pump-and-dump techniques to raise their share prices. Some of these businesses have attracted sizable interest from investors after simply […]

Read More

Silicon Valley Venture Capitalists Still Shy Away From Cannabis

Some venture capitalists in Silicon Valley are still hesitant to invest in the cannabis industry, and at least one well-known investor blamed the industry’s current image for the lack of participation. Lisa Suennen, an influential investor in San Francisco and managing partner of Venture Valkyrie Consulting, said some tech investors aren’t sure if “there are good […]

Read More